The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
Abstract
Cardiovascular accidents represent the most important cause of death in patients with Cushing's syndrome. This prospective study aims at evaluating carotid arteries by echo-Doppler ultrasonography and clinical and metabolic markers of atherosclerosis in 25 patients with Cushing's disease (CD) before and after 1 yr of remission. Thirty-two sex- and age-matched subjects (control-1) and 32 body mass index-matched subjects (control-2) served as controls. At diagnosis, CD patients had higher body mass index, waist to hip ratio (WHR), total, low-density lipoprotein-cholesterol and total/high-density lipoprotein (HDL) ratio, glucose and insulin, as well as lower HDL-cholesterol than control-1; they had higher WHR and total/HDL ratio and lower HDL-cholesterol than control-2. They also had higher intima-media thickness (IMT), and lower systolic lumen diameter and distensibility coefficient (DC) than either control group. Atherosclerotic plaques were detected in 31.2% of patients, 0 control-1, and 6.2% of control-2 subjects. One year after remission, WHR, LDL-cholesterol, and IMT significantly decreased, whereas systolic lumen diameter and DC significantly increased. However, all of the above parameters were still abnormal compared with control-1, but not control-2. A significant correlation was found between WHR, glucose and insulin levels, and right and left carotid IMT. WHR was the best predictor of left IMT and left DC in active, but not in cured, patients. The duration of hypercortisolism was the best predictor of right DC in active but not in cured patients. In conclusion, patients with CD have severe atherosclerotic damage. The persistence of a metabolic syndrome, vascular damage, and atherosclerotic plaques after cortisol level normalization makes these subjects still at high cardiovascular risk despite disease remission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From % to % of patients with endogenous CS have DM, and % to % have defective glucose tolerance, so the overall prevalence of glucose metabolism impairments can come close to %, as shown in Table (, , -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
In the citing paper
“Controlling hypercortisolism is the first step toward improving glucose metabolism in patients with endogenous CS, but different treatments for hypercortisolism may affect the outcome of diabetes, regardless of how well cortisol excess is corrected (, , , , , , ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
In the citing paper
“Other prospective studies [Faggiano et al., (); Giordano et al., ()] reported similar findings in patients with CS before and year after remission was achieved thanks to pituitary neurosurgery, pituitary irradiation, or adrenalectomy.”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Williams Textbook of Endocrinology
Melmed, S., & Polonsky, K. S. (2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,715
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1×
“(28), impairment of glucose tolerance (29), and gestational diabetes (30).”
BackgroundBorch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Diabetes and Endothelial Dysfunction: A Clinical Perspective
Calles-Escandón, J., & Cipolla, M. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0417 · Cited by 657
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 450
Self-citationEndothelial dysfunction in diabetes mellitus.
Cosentino, F., & Lüscher, T. F. (1998) · PubMed · Cited by 259
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 359
Carroll, T. B., Javorsky, B. R., & Findling, J. W. (2016) · Endocrine Practice · doi:10.4158/ep161380.or · Cited by 41
Baroni, M. G., Giorgino, F., Pezzino, V., Scaroni, C., & Avogaro, A. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0404-6 · Cited by 41
Rizzoni, D., Porteri, E., Ciuceis, C. D., Rodella, L. F., Paiardi, S., Rizzardi, N., Platto, C., Boari, G. E. M., Pilu, A., Tiberio, G. A. M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1588 · Cited by 42
Modulation of 11β-Hydroxysteroid Dehydrogenase as a Strategy to Reduce Vascular Inflammation
Hadoke, P. W. F., Kipari, T. M. J., Seckl, J. R., & Chapman, K. E. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0320-1 · Cited by 42
Cardiovascular health and mortality in Cushing’s disease
Coulden, A., Hamblin, R., Wass, J., & Karavitaki, N. (2022) · Pituitary · doi:10.1007/s11102-022-01258-4 · Cited by 30
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 37
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
Keil, M. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1123 · Cited by 38
Glucose metabolism in Cushing's syndrome
Sharma, A. R., & Vella, A. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000537 · Cited by 41
Effects of endocrine disorders on lipids and lipoproteins
Newman, C. B. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101667 · Cited by 37
Vascular Dysfunction in Horses with Endocrinopathic Laminitis
Morgan, R., Keen, J., Walker, B. R., & Hadoke, P. W. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163815 · Cited by 36
The Interaction of Insulin and Pituitary Hormone Syndromes
Schernthaner-Reiter, M. H., Wolf, P. S., Vila, G., & Luger, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626427 · Cited by 43
Echocardiographic alterations in patients with non-functioning adrenal incidentaloma
Ermetici, F., Dall’Asta, C., Malavazos, A. E., Coman, C., Morricone, L. F., Montericcio, V., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346410 · Cited by 36
Prázný, M., Ježková, J., Horová, E., Lazárová, V., Hána, V., Kvasnička, J., Pecen, L., Marek, J., Škrha, J., & Kršek, M. (2008) · Physiological Research · doi:10.33549/physiolres.931126 · Cited by 36
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 41
Martin, M. D., Giraldi, F. P., & Cavagnini, F. (2006) · Pituitary · doi:10.1007/s11102-006-0407-6 · Cited by 35
Oßwald, A., Deutschbein, T., Berr, C., Plomer, E., Mickisch, A., Ritzel, K., Schopohl, J., Beuschlein, F., Faßnacht, M., Hahner, S., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0212 · Cited by 33
Faggiano, A., Melis, D., Alfieri, R., Martino, M. D. D., Filippella, M., Milone, F., Lombardi, G., Colao, A., & Pivonello, R. (2005) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2005-0656 · Cited by 48
Self-citationFein, H. G., Vaughan, T. B., Kushner, H., Cram, D., & Nguyen, D. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0059-5 · Cited by 32
Management of Dyslipidemia in Cushing’s Syndrome
Greenman, Y. (2010) · Neuroendocrinology · doi:10.1159/000314294 · Cited by 31
Aspartame: Should Individuals with Type II Diabetes be Taking it?
Choudhary, A. K. (2017) · Current Diabetes Reviews · doi:10.2174/1573399813666170601093336 · Cited by 32
Uziębło‐Życzkowska, B., Krzesinński, P., Witek, P., Zielinński, G., Jurek, A., Gielerak, G. G., & Skrobowski, A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00222 · Cited by 30
Cardiovascular and Metabolic Impact of Glucocorticoid Replacement Therapy
Johannsson, G., & Ragnarsson, Ó. (2014) · Frontiers of hormone research · doi:10.1159/000360556 · Cited by 30
Ragnarsson, Ó., Glad, C. A. M., Bergthorsdottir, R., Almqvist, E. G., Ekerstad, E., Widell, H., Wängberg, B., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0747 · Cited by 33
Hatipoglu, B. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23197 · Cited by 18
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status
Clarke, S. A., Eng, P. C., Comninos, A. N., Lazarus, K., Choudhury, S., Tsang, C., Meeran, K. M., Tan, T., Dhillo, W. S., & Abbara, A. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae016 · Cited by 33
The Endocrine System and the Heart: A Review
Rhee, S. S., & Pearce, E. N. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2010.10.016 · Cited by 30
Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 36
Resistant Hypertension Workup and Approach to Treatment
Makris, A. P., Seferou, M., & Papadopoulos, D. P. (2010) · International Journal of Hypertension · doi:10.4061/2011/598694 · Cited by 29
Cushing's Disease Complicated with Thrombosis in a Dog
Teshima, T., Hara, Y., TAODA, T., Koyama, H., Takahashi, K., Nezu, Y., Harada, Y., Yogo, T., NISHIDA, K., OSAMURA, R. Y., et al. (2008) · Journal of Veterinary Medical Science · doi:10.1292/jvms.70.487 · Cited by 27
Should we evaluate for cardiovascular disease in patients with Cushing’s syndrome?
Fallo, F., & Sonino, N. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03610.x · Cited by 28
Prevalencia, etiología y cuadro clínico del síndrome de Cushing
Vargas, M. L., & da Costa, C. V. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)70191-3 · Cited by 28
Clinical and biochemical manifestations of Cushing’s
Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · Pituitary · doi:10.1007/s11102-014-0631-4 · Cited by 27
3 Rationale for treatment and therapeutic options in Cushing's disease
Stewart, P. M., & Petersenn, S. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(09)70004-1 · Cited by 26
The Effect of Alpha-Lipoic Acid on Mitochondrial Superoxide and Glucocorticoid-Induced Hypertension
Ong, S. L. H., Vohra, H., Zhang, Y., Sutton, M., & Whitworth, J. A. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/517045 · Cited by 26
Glucocorticoids are active players and therapeutic targets in atherosclerotic cardiovascular disease
van der Sluis, R. J., & Hoekstra, M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110728 · Cited by 27
Oh, J. S., Kim, H. J., Hann, H. J., Kang, T., Kim, D. S., Kang, M. J., Lee, J. Y., Shim, J. J., Lee, M. R., & Ahn, H. S. (2020) · Pituitary · doi:10.1007/s11102-020-01084-6 · Cited by 25
Hypercoagulability in Cushing’s syndrome: From arterial to venous disease
St‐Jean, M., Lim, D. S. T., & Langlois, F. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101496 · Cited by 25
Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure
Sieber‐Ruckstuhl, N. S., Burla, B., Spoerel, S., Schmid, F. D., Venzin, C., Cazenave‐Gassiot, A., Bendt, A. K., Torta, F. T., Wenk, M. R., & Boretti, F. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-42190-1 · Cited by 24
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
McMinn, D. L., Rew, Y., Sudom, A. M., Caille, S., DeGraffenreid, M. R., He, X., Hungate, R. W., Jiang, B., Jaén, J. C., Julian, L. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.026 · Cited by 24
Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 in Antidiabetic Therapy
Wang, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_6 · Cited by 24
Poledniczek, M., Neumayer, C., Kopp, C. W., Schlager, O., Gremmel, T., Józkowicz, A., Gschwandtner, M. E., Koppensteiner, R., & Wadowski, P. P. (2023) · Biomedicines · doi:10.3390/biomedicines11082284 · Cited by 25
A prospective study of appetite and food craving in 30 patients with Cushing’s disease
Geer, E. B., Lalazar, Y., Couto, L., Cohen, V. V., Lipton, L. R., Shi, W., Bagiella, E., Conwell, I. M., Bederson, J. B., Kostadinov, J., et al. (2015) · Pituitary · doi:10.1007/s11102-015-0690-1 · Cited by 25
Cardiomyopathies and Adrenal Diseases
Petramala, L., Concistrè, A., Olmati, F., Saracino, V., Chimenti, C., Frustaci, A., Russo, M. A., & Letizia, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145047 · Cited by 23
Impact of Weight-Loss Medications on the Cardiovascular System
Drolet, B., Simard, C., & Poirier, P. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00005 · Cited by 23
Bassareo, P. P., Marras, A. R., Pasqualucci, D., & Mercuro, G. G. (2010) · Cardiology in the Young · doi:10.1017/s1047951110000727 · Cited by 23
Setola, E., Losa, M., Lanzi, R., Lucotti, P., Monti, L. D., Castrignanò, T., Galluccio, E., Giovanelli, M. A., & Piatti, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02774.x · Cited by 23
Surgical remission of Cushing's syndrome reduces cardiovascular risk
Terzolo, M., Allasino, B., Pia, A., Peraga, G., Daffara, F., Laino, F., Ardito, A., Termine, A., Paccotti, P., Berchialla, P., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0555 · Cited by 22
Takagi, S., Tanabe, A., Tsuiki, M., Naruse, M., & Takano, K. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-198 · Cited by 23
Laura, E., Sosa, E., Nayeli, M., & Moisés, M. (2013) · Endocrine Practice · doi:10.4158/ep12247.or · Cited by 23
Russell, M., Bredella, M. A., Tsai, P., Mendes, N., Miller, K. K., Klibanski, A., & Misra, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0380 · Cited by 22
Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis
Wang, X., Chen, B., Lv, N., Liu, Q., & Dang, A. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2819-4 · Cited by 21
Biochemical markers for cardiovascular risk following treatment in endogenous Cushing’s syndrome
Kristo, C., Ueland, T., Godang, K., Aukrust, P., & Bollerslev, J. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346383 · Cited by 21
Cardiovascular Manifestations of Endocrine Dysfunction
Deegan, R., & Furman, W. R. (2011) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2010.12.001 · Cited by 21
Ross, I. L., Levitt, N. S., van der Merwe, L., Schatz, D., Johannsson, G., Dandara, C., Pillay, T. S., & Blom, D. J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0808 · Cited by 21
Camozzi, V., Sanguin, F., Albigier, N., Scaroni, C. M., Mantero, F., Zaninotto, M., Frigo, A., Piccolo, M., & Luisetto, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0800 · Cited by 22
Wolf, P. S., Winhofer, Y., Krššák, M., & Krebs, M. (2017) · Endocrine Connections · doi:10.1530/ec-17-0031 · Cited by 23
Aranda, G. B., Fernandez‐Ruiz, R., Palomo, M., Romo, M., Mora, M., Halperín, I., Casals, G., Enseñat, J., Vidal, Ó., Díaz‐Ricart, M., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13521 · Cited by 21
Rak, B., Maksymowicz, M., Pękul, M., & Zieliński, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.672178 · Cited by 21
Ayari, H., Legedz, L., Cerutti, C., Lantelme, P., Feugier, P., Gustin, M., Lohez, O. D., Nehme, A., Li, J. Y., GHARBI-CHIHI, J., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1193-7 · Cited by 19
Pronóstico del paciente tratado de síndrome de Cushing
Aulinas, A., Valassi, E., & Webb, S. M. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.03.008 · Cited by 19
Auvinen, H. E., Coomans, C. P., Boon, M. R., Romijn, J. A., Biermasz, N. R., Meijer, O. C., Havekes, L. M., Smit, J. W. A., Rensen, P. C. N., & Pereira, A. M. (2013) · Physiological Reports · doi:10.1002/phy2.103 · Cited by 19
Impact of cortisol on blood pressure and hypertension-mediated organ damage in hypertensive patients
Haddad, C., Courand, P., Berge, C., Harbaoui, B., & Lantelme, P. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002801 · Cited by 19
Auvinen, H. E., Wang, Y., Princen, H. M. G., Romijn, J. A., Havekes, L. M., Smit, J. W. A., Meijer, O. C., Biermasz, N. R., Rensen, P. C. N., & Pereira, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063882 · Cited by 19
Unmet needs in Cushing’s syndrome: the patients’ perspective
Valassi, E., Chiodini, I., Feelders, R. A., Andela, C. D., Abou-Hanna, M., Idres, S., & Tabarin, A. (2022) · Endocrine Connections · doi:10.1530/ec-22-0027 · Cited by 18
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome
Battocchio, M., Rebellato, A., Grillo, A., Dassie, F., Maffei, P., Bernardi, S., Fabris, B., Carretta, R., & Fallo, F. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-100385 · Cited by 18
Adrenal steroids and the metabolic syndrome
Thomson, S. P., Stump, C. S., Kurukulasuriya, L. R., & Sowers, J. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0093-4 · Cited by 17
Ledda, A., González, M., Gulfo, J., Ludovico, I. D., Ramella, N. A., Toledo, J., Garda, H. A., Grasa, M., & Esteve, M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.04.020 · Cited by 16
Mortality of Patients with Cushing's Disease.
Ntali, G., Hakami, O. A., Wattegama, M., Ahmed, S., & Karavitaki, N. (2020) · Experimental and clinical endocrinology & diabetes · doi:10.1055/a-1197-6380 · Cited by 16
Jurek, A., Krzesiński, P., Gielerak, G. G., Witek, P., Zieliński, G., Kazimierczak, A., Wierzbowski, R., Banak, M., & Uziębło‐Życzkowska, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.751743 · Cited by 17
The mechanism of action and side effects of epidural steroids
Baqai, A., & Bal, R. (2009) · Techniques in Regional Anesthesia and Pain Management · doi:10.1053/j.trap.2009.06.009 · Cited by 17
Wagenmakers, M. A. E. M., Roerink, S. H. P. P., Schreuder, T. H. A., Plantinga, T. S., Holewijn, S., Thijssen, D. H. J., Smit, J. W. A., Rongen, G. A. P. J. M., Pereira, A. M., Wagenmakers, A. J. M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1674 · Cited by 16
Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome
Chandran, D. S., Jaryal, A. K., Jyotsna, V. P., & Deepak, K. K. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0030 · Cited by 17
Deng, L., Zhang, Y., Chen, Z., Zhao, Z., Zhang, K., & Wu, J. (2019) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2019.2951922 · Cited by 16
Wang, Y., Li, D., Chen, H., Li, Z., Feng, B., & Weng, X. (2023) · Biomolecules · doi:10.3390/biom13010171 · Cited by 17
Role of adrenalectomy in recurrent Cushing's disease
Ding, X., Li, H., Yan, W., Gao, Y., & Li, X. (2010) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2010.13.008 · Cited by 16
Soluble adhesion molecules levels in patients with Cushing’s syndrome before and after cure
Ermetici, F., Malavazos, A. E., Corbetta, S., Eller-Vainicher, C., Cannavò, S., Corsi, M. M., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346381 · Cited by 16
Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks
Makri, A., Cheung, A., Sinaii, N., Remaley, A. T., Sampson, M. L., Keil, M. F., Belyavskaya, E., Lyssikatos, C., Sierra, M. D. L. L., Stratakis, C. A., et al. (2019) · Pediatric Research · doi:10.1038/s41390-019-0438-0 · Cited by 16
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome
Araujo-Castro, M., Lamas, C., Nowak, E., Newell-Price, J. D. C., Reincke, M., & Castinetti, F. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf042 · Cited by 19
Witek, P., Zieliński, G., Szamotulska, K., Witek, J., & Zgliczyński, W. (2012) · PubMed · Cited by 15
Su, X., Pradaux, F., THOMAS, M. P., Szeto, M. W. Y., Halem, H. A., Culler, M. D., Vicker, N., & Potter, B. V. L. (2010) · ChemMedChem · doi:10.1002/cmdc.201000081 · Cited by 15
Lustig, R. H. (2010) · Endocrine updates · doi:10.1007/978-1-4419-7034-3 · Cited by 23
Effect of hypercortisolism control on high blood pressure in Cushing's syndrome.
Gomez, R. M., Albiger, N. M. E., Díaz, A. G., Moncet, D., Pitoia, F., & Bruno, O. D. (2007) · PubMed · Cited by 15
Lipid profile abnormalities associated with endocrine disorders
Szczepanek‐Parulska, E., Sokołowski, J., Dmowska, D., Klimek, J., Stasikowski, T., Zdebski, P., Olejarz, M., Gac, A., Bartecki, M., & Ruchała, M. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0059 · Cited by 14
Autonomous hypercortisolism: definition and clinical implications
Reimondo, G., Puglisi, S., Pia, A. R., & Terzolo, M. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02884-5 · Cited by 14
Baroni, M. G., Giorgino, F., PEZZINO, V., Scaroni, C. M., & Avogaro, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.001 · Cited by 14
Tsai, C., Liao, C., Wu, X., Chen, Z., Pan, C., Chang, Y., Lee, B., Chou, C., Chang, C., Wu, V., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf007 · Cited by 13
Hormones and Arterial Stiffness in Patients with Chronic Kidney Disease
Güngör, Ö., Kırçelli, F., Voroneanu, L. E., Covic, A. C., & Ok, E. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.18580 · Cited by 13
Yadav, A., Jahan, A., Yadav, T. P., Sachdev, N., Chitkara, A., & Asare, R. (2013) · The Indian Journal of Pediatrics · doi:10.1007/s12098-013-1035-6 · Cited by 13
Tang, A. R., Rabi, D. M., Lavoie, K., Bacon, S., Pilote, L., & Kline, G. A. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317734323 · Cited by 13
Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism
Karaca, Z., Açmaz, B., Açmaz, G., Tanrıverdi, F., Unluhizarci, K., Aribaş, S., Sahin, Y., & Keleştimur, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0938 · Cited by 13
Dullaart, R. P. F., Schols, J. L., van der Steege, G., Zelissen, P. M. J., Sluiter, W. J., & van Beek, A. P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03196.x · Cited by 13
An Overview of Cardiovascular Risk in Pituitary Disorders
Ntali, G., Markussis, V., & Chrisoulidou, A. (2024) · Medicina · doi:10.3390/medicina60081241 · Cited by 12
Unusual infections and thrombotic events in Cushing’s syndrome
Barbot, M., Lazzara, M., Mazzeo, P., & Giraldi, F. P. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02454-8 · Cited by 13
Rebellato, A., Grillo, A., Dassie, F., Sonino, N., Maffei, P., Martini, C., Paoletta, A., Fabris, B., Carretta, R., & Fallo, F. (2014) · Endocrine · doi:10.1007/s12020-014-0164-7 · Cited by 12
The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome
Herndon, J. S., Kaur, R. J., Romportl, M., Smith, E., Koenigs, A., Partlow, B. J., Arteaga, L., & Bancos, I. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab169 · Cited by 13
Kuroki, Y., Kaji, H., Kawano, S., Kanda, F., Takai, Y., Kajikawa, M., & Sugimoto, T. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3161 · Cited by 12
Su, X., Pradaux, F., Vicker, N., THOMAS, M. P., Halem, H. A., Culler, M. D., & Potter, B. V. L. (2011) · ChemMedChem · doi:10.1002/cmdc.201100182 · Cited by 12
Lam, H., Kuo, S.-M., Chuang, M.-J., Keng, H.-M., Lin, P.-R., Liu, G., Hsu, C., Howng, S., & Tai, M. (2006) · PubMed · Cited by 12
Fano, M. D., Falorni, A., Malara, M., Porcellati, F., & Fanelli, C. G. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s466328 · Cited by 11
Bosman, A., van den Beld, A. W., Feelders, R. A., & Zillikens, M. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.733793 · Cited by 11
Metadata
- Authors
- Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Colao, Annamaria
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2527-2533
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2107774273
- Cited by
- 358
- References
- 30
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 17 · 2021: 13 · 2020: 14 · 2019: 13 · 2018: 7 · 2017: 19 · 2016: 19 · 2015: 18 · 2014: 22 · 2013: 24 · 2012: 20
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Cushing's disease, carotid artery stiffness, carotid intima-media thickness, atherosclerosis, cardiovascular risk factors, remission, waist-to-hip ratio, metabolic syndrome, carotid distensibility, atherosclerotic plaque, HDL cholesterol, insulin resistance
- MeSH terms
- Adult, Arteriosclerosis, Cardiovascular Diseases, Cushing Syndrome, Elasticity, Female, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Remission Induction, Risk Factors, Time Factors, Ultrasonography, Carotid Artery, Common
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
